Investor

The U.S. International Trade Commission determined Apple Watches with ECG functionality violate AliveCor patents, but an import ban is on hold until appeals wrap up in a case before the U.S. Patent and Trademark Office's Patent Trial and Appeal Board.

Nomi Health appointed its first chief product officer, and Hims & Hers announced that its first chief medical officer has returned to the role.

Aegis Ventures' John Beadle discusses partnerships between venture capital firms and health systems, the move from direct-to-consumer to business-to-business models and what digital health investment could look like next year.

The execs spotlight the year's rise of home healthcare, drop in digital health investment and expanded use of AI, in addition to the value of virtual care.

The investment will support Nectar's growth nationwide, fund clinical trials and help the company open a physical location.

The startup offers access to advocates who can help family caregivers make plans or solve problems as well as a digital health platform.

The companies first partnered in 2020 to develop a prescription digital therapeutic for schizophrenia. They said a treatment strategy for the condition "would benefit from a multi-product approach."

Click Therapeutics received FDA Breakthrough Device Designation for a prescription digital therapeutic for episodic migraine, and Superior HealthPlan announced a home care partnership with MedArrive and Brave Health.

Also, a Thai language speech recognition AI has been deployed for screening depression in Thailand.

It delivers ethnicity-specific brain scan analysis within 20 minutes.